Early stage prostate cancer If the cancer Prostate 1 bph clinical study is small and localized, it is usually managed by one of the following treatments: Watchful waiting or monitoring: PSA blood levels are regularly checked, Prostate 1 bph clinical study but there is no immediate action. The risk Prostate 1 bph clinical study prostate 1 bph clinical study of side-effects sometimes outweighs the need for immediate treatment for this slow-developing cancer. Radical prostatectomy: The prostate is surgically removed. Traditional surgery requires a hospital Prostate 1 bph clinical study prostate 1 bph clinical study stay of up to 10 days, with a recovery time of up to 3 months. Robotic keyhole surgery involves a shorter hospitalization and recovery Prostate 1 bph clinical study period, but it can be more expensive. Patients should speak to their insurer about coverage. Brachytherapy: Radioactive seeds are implanted into the prostate to deliver targeted radiation treatment.
Conformal radiation therapy: Radiation beams are shaped so that the region where they overlap is as close to the same shape as the organ or Region that requires treatment.
This minimizes healthy tissue exposure to radiation.
Intensity modulated Prostate 1 bph clinical study radiation therapy: Beams with variable intensity are used. This Prostate 1 bph clinical study is an advanced form of conformal radiation Prostate 1 bph clinical study therapy. In the early Prostate gland cancer stages, patients may receive radiation therapy combined with hormone therapy for 4 to 6 months. Treatment recommendations depend on individual prostate 1 bph clinical study cases. The patient should discuss all available options with their urologist or oncologist. Advanced prostate cancer Advanced cancer is more aggressive and will have spread further throughout the body. Chemotherapy may be recommended, as it can kill cancer cells around the body. Androgen deprivation therapy (ADT), or androgen suppression Prostate 1 bph clinical study therapy, is a hormone treatment that reduces the effect of androgen.
Androgens are male hormones that can stimulate cancer growth. ADT can slow down and prostate 1 bph clinical study even stop cancer growth by reducing androgen levels. The patient will likely need long-term hormone therapy. Even if the Hormone therapy stops working after a prostate 1 bph clinical study while, there may be other options. Participation in Prostate 1 bph clinical study clinical trials is one option that a patient may wish to discuss with the doctor. Radical Prostate 1 bph clinical study prostatectomy is not currently an option for advanced cases, as it does not treat the cancer that has spread to other parts of the body. Fertility As the prostate is directly involved with sexual reproduction, removing it affects semen production and Prostate 1 bph clinical study Prostate 1 bph clinical study fertility. Radiation therapy affects the prostate tissue and often reduces the ability to father children. The Prostate 1 bph clinical study sperm can be damaged and the semen insufficient for transporting sperm. Non-surgical options, too, can severely inhibit a man's reproductive capacity.
Options for preserving these functions can include donating to a sperm bank before surgery, or having sperm extracted directly from the testicles for artificial insemination into an egg. However, the success of these options is never guaranteed. Patients with prostate cancer can speak to a fertility doctor if they still intend to father children. This means that its fluids and secretions are intended for use outside of the body. The prostate produces the fluid that nourishes Prostate 1 bph clinical study Prostate 1 bph clinical study and transports sperm on their journey to fuse prostate 1 bph clinical study with a female ovum, or egg, and produce human life. The prostate contracts and forces these fluids out during orgasm.
The protein excreted by the prostate, prostate-specific antigen (PSA), helps semen retain its liquid state.
An excess of this protein in Prostate 1 bph clinical study the blood is one of the first signs of prostate cancer. The urethra is tube through which sperm and urine exit the Body.
As such, prostate 1 bph clinical study the prostate is also responsible for urine control. It can tighten and restrict the flow of urine through the urethra using thousands of tiny muscle fibers.
Tiny changes occur in the shape and size of the prostate gland cells, known as prostatic intraepithelial neoplasia (PIN). This tends to happen slowly and does not show symptoms until further into the progression. Nearly 50 percent of all men over the age of 50 years have PIN. High-grade PIN is considered pre-cancerous, and it requires further investigation. Prostate cancer can be successfully treated prostate 1 bph clinical study if it is diagnosed before metastasis, but if it spreads, it is more dangerous. Stages Staging takes into account the size and extent of the tumor and the scale of the metastasis (prostate 1 bph clinical study whether it has traveled to other organs and tissues).
Prostatectomia q es
Prostatic adenoma obstruction
Prostate 4.7
| 12.11.2018 - Vasmoylu_Kayfusha |
| Can severely inhibit surgery, or having sperm extracted directly from the testicles and your. |
| 12.11.2018 - K_E_N_Z_O |
| Shape and size of the prostate rare among men. |
| 12.11.2018 - 665 |
| Can cause serious forms of female tissues known as hematuria) Many of these signs of prostate cancer develop slowly. |
| 12.11.2018 - STAR_THE_FIRE |
| Starting to urinate or emptying your bladder a weak flow when you urinate cancer. |
No comments:
Post a Comment